Two-year deal expected to result in additional $16m revenue annually HIC to distribute two products to customers in 27 countries One product contains popular nicotinamide mononucleotide (NMN) ingredient NMN market projected to reach US$386 million globally by the end of…

30 August 2023 Glenn completed a successful live TV interview. EZZ Life Sciences (EZZ) Chair Glenn Cross discusses impressive FY23 results, highlighting a 176% net profit increase to nearly $4 million and a 147% revenue surge. The growth is attributed…